The main therapeutic areas in which we are working are:
Autoimmune diseases directly affect more than 27 million people in Europe alone
Autoimmune diseases directly affect more than 27 million people in Europe alone
All diseases for which granulocyte-monocyte/macrophage adsorption apheresis device (GMA) is indicated belong to the group of Autoimmune Diseases (AD). An AD is a pathological condition in which the immune system becomes the aggressor, attacking and destroying healthy organs.
There are more than 80 AD of which Rheumatoid Arthritis, Psoriasis, Systemic Lupus Erythematosus and Inflammatory Bowel Disease are particularly prevalent.
Copyright 2020 © Adacyte Therapeutics | C/ Jesús Serra Santamans, 5, 08174 Sant Cugat del Vallès (Barcelona)
Legal Advice | Privacy Policy | Social Network Privacy Policy | Cookies Policy | EN-COR-0320001